Biotech
Exact Sciences
Exact Sciences raises $125M Series D at $1.5B valuation
Madison, WIFebruary 25, 20151 min read
Total Raised
$125M
Valuation
$1.5B
Latest Round
Series D
Employees
5000+
Exact Sciences: Series D Funding Round
Exact Sciences has successfully raised $125M in Series D funding, reaching a valuation of $1.5B.
Company Overview
Cancer screening and diagnostics
Funding Details
The Series D round was led by Casdin Capital, with participation from Fidelity.
Company Information
- Headquarters: Madison, WI
- Founded: 1995
- Employees: 5000+
- Category: Biotech
Investment
Exact Sciences plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Casdin Capital: Verified investor in Series D
- Fidelity: Verified investor in Series D
Company Info
Headquarters
Madison, WI
Founded
1995
Team Size
5000+
Last Round
$125M(Feb 2015)
Investors (2)
C
Casdin CapitalLeadLead Investor
Verified investor in Series D
F
FidelityInvestor
Verified investor in Series D
Share
Related Reports
Biotech
AusperBio
AusperBio Raises $73M Series B
Biotech company developing AHB-137, an antisense oligonucleotide for chronic hepatitis B treatment entering phase 2 trials
David Chen
Dec 30, 2025
0 min read•$73M Series B
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free